Weight-loss drugs: 'We need good regulation but hopefully prices will come down'

Ozempic, Mounjaro, and other weight-loss wonder drugs had quite a week as the WHO, governments, pharma firms, patients, and advocates consider cost versus efficacy

One advocate said: 'If you treat obesity, you effectively prevent other cardiorenal metabolic diseases'. Picture: iStock

Weight-loss wonder drugs have had quite a week. 

First, they were described as a great source of hope by the WHO (World Health Organization) but, within days, some were labelled as too expensive for the public health system in Ireland.